z-logo
open-access-imgOpen Access
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: A phase 4 trial
Author(s) -
Ana Cristina Medeiros-Ribeiro,
Nádia Emi Aikawa,
Carla G. S. Saad,
Emily Figueiredo Neves Yuki,
Tatiana do Nascimento Pedrosa,
Solange R. G. Fusco,
Priscila T. Rojo,
Rosa Maria Rodrigues Pereira,
Samuel Katsuyuki Shinjo,
Danieli Andrade,
Percival Degrava Sampaio-Barros,
Carolina Torres Ribeiro,
Giordano B H Deveza,
Vanessa Martins,
Clóvis A. Silva,
Marta Heloísa Lopes,
Alberto J. S. Duarte,
Leila Antonângelo,
Ester C. Sabino,
Esper G. Kallás,
Sandra Gofinet Pasoto,
Eloísa Bonfá
Publication year - 2021
Publication title -
sbr 2021 congresso brasileiro de reumatologia
Language(s) - English
Resource type - Conference proceedings
DOI - 10.47660/cbr.2021.1852
Subject(s) - immunogenicity , medicine , immunology , virology , antibody

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here